Intersection of ID & OUD Epidemic: What ID Clinicians Should Know
The epidemic of opioid use disorder has led to substantial increases in new cases of HCV and HIV infection, as well as hospitalizations for other OUD-related infections.
The epidemic of opioid use disorder has led to substantial increases in new cases of HCV and HIV infection, as well as hospitalizations for other OUD-related infections.
Researchers found substantial room for improvement in the delivery of substance use and mental health counseling and treatment and HIV/STD prevention counseling.
A substantial proportion of these individuals diagnosed with HIV, psychiatric disorders, and substance use disorders are out of care and urgently require intervention.
Katie Burk, MPH, presented measures undertaken by the city of San Francisco to provide integrated responses to the concurrent HIV/HCV and opioid public health epidemics.
The HIV Medicine Association of the Infectious Diseases Society of America has released new guidelines for the management of chronic pain in patients living with human immunodeficiency virus.
Patients with a diagnosis of HIV and peripheral neuropathy often have ≥1 additional pain disorders.
A large proportion of HIV-positive patients experience frequent headaches that often impact their quality of life.
The HIV Medicine Association of the Infectious Disease Society of America recommends that people living with HIV be screened for pain and offered both nonpharmacologic and pharmacologic treatment options.
The World Health Organization published new guidelines for managing HIV drug resistance in countries in which pretreatment HIV drug resistance to non-nucleoside reverse transcriptase inhibitors (NNRTIs) is prevalent.
Patients with HIV who underwent immediate ART saw significant decreases in bone mineral density; however, the benefits of beginning ART early outweigh the outcomes related to decreased BMD.